Company
Visterra
Also known as Visterra, Inc
- Business model
- B2B
- Legal name
- Visterra, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Visterra is a biologics research and early-stage clinical development company developing therapies for patients with immune-mediated and other hard-to-treat diseases.
Funding snapshot
- Total raised
- $43.4MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $34.2M2012-05-14
Funding rounds
- Round, 2012
- $34.2M2012-05-14, SEC form D sold, 16 investors
- Round, 2010
- $6M2010-09-03, SEC form D sold, 7 investors
- Round, 2009
- $3.2M2009-11-30, SEC form D sold, 7 investors
Loading relationship preview